SlideShare une entreprise Scribd logo
1  sur  94
Bioavailability  Of  Disperse Dosage Forms By Mohammad Sohail Mphil pharmaceutics Islamia university Bahawalpur [email_address]
Bioavailability Of Disperse Dosage Forms ,[object Object],[object Object],[object Object],[object Object],[object Object]
Relative Bioavailability ,[object Object],[object Object]
RBA ,[object Object],[object Object],[object Object],[object Object],[object Object]
Absolute Bioabavailability ,[object Object],[object Object],[object Object]
Absolute Bioavailability ,[object Object],[object Object],[object Object],[object Object]
Difference between Absolute and Relative  Bioavailability ,[object Object],[object Object],[object Object],[object Object],[object Object]
AB vs RBA   Drug Product AUC ( mcg/ml . hr ) A  IV Injection 100 B  Oral dosage form (Refer) 50 C  Oral dosage form (generic) 40
Bioequivalent Drug Products ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Disperse Systems ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Routes Of Drug Administration ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Properties Of Disperse Dosage Form ,[object Object],[object Object],[object Object],[object Object]
Properties Of Disperse Dosage Form ,[object Object],[object Object],[object Object],[object Object]
Advantages Of Disperse Dosage Form ,[object Object],[object Object],[object Object],[object Object]
Formulation Factors Affecting Drug Release  From Disperse Systems : ,[object Object],[object Object],[object Object],[object Object],[object Object]
Wetting ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Particle Size ,[object Object],[object Object],[object Object],[object Object]
Particle Size ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Viscosity ,[object Object],[object Object],[object Object],[object Object]
Viscosity ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Drug release from disperse systems ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Absorption Barriers   ,[object Object],[object Object]
Barriers for Skin
Barriers For Skin ,[object Object],[object Object],[object Object],[object Object]
pathways for percutaneous absorption: ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Barriers For Eye
Barriers For Eye ,[object Object],[object Object],[object Object]
Barriers For Eye ,[object Object],[object Object],[object Object]
Barriers For GIT
Barriers For GIT ,[object Object],[object Object],[object Object],[object Object]
Barriers for GIT ,[object Object],[object Object]
Barrier for Pulmonary Drug Delivery   ,[object Object],[object Object],[object Object],[object Object]
Barriers for Pulmonary Drug Delivery ,[object Object],[object Object],[object Object]
Absorption Factors SKIN EYE GIT Barrier Stratum corneum Superficial layer of epithelium  Epithelium  Thickness  8-26 layers  5-6 layers  1 layer hydration 10-25% 78% High area 2-25cm 2 1.3cm 2 2,000,000
Physiological Factors Affecting Absorption ,[object Object],[object Object],[object Object],[object Object],[object Object]
Factors affecting Percutaneous Absorption ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Factors affecting Percutaneous Absorption ,[object Object],[object Object],[object Object],[object Object]
Factors affecting Percutaneous Absorption ,[object Object],[object Object],[object Object],[object Object]
Percutaneous Absorption ,[object Object],[object Object],[object Object],[object Object],[object Object]
Percutaneous Absorption ,[object Object],[object Object],[object Object]
Factors affecting Ophthalmic Absorption ,[object Object],[object Object],[object Object],[object Object],[object Object]
Factors affecting Ophthalmic Absorption ,[object Object],[object Object],[object Object]
Factors affecting G.I.T Absorption ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Factors affecting G.I.T Absorption ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
pH Location pH Stomach Duodenum Jejunum Ileum Colon Rectum 1.5-3.5 5-7 6-7 6.0-7.5 5.5-7.0 7
pH ,[object Object],[object Object]
Metabolism ,[object Object],[object Object],[object Object],[object Object],[object Object]
Metabolism ,[object Object],[object Object],[object Object],[object Object]
Metabolism ,[object Object],[object Object]
Presence Of Food ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Presence Of Food ,[object Object],[object Object]
Individual variation ,[object Object],[object Object],[object Object],[object Object]
Gender ,[object Object],[object Object]
Race ,[object Object],[object Object],[object Object]
Example ,[object Object],[object Object],[object Object],[object Object]
Age ,[object Object],[object Object],[object Object]
Methods Of Assessing Bioavailability Of Drugs ,[object Object],[object Object]
Methods Of Assessing Bioavailability Of Drugs ,[object Object],[object Object],[object Object],[object Object],[object Object]
Plasma Drug Concentration ,[object Object],[object Object],[object Object]
Plasma concentration vs. time profile of a single dose of a drug ingested orally Plasma Concentration
Key Parameters: ,[object Object],[object Object],[object Object],[object Object],[object Object]
AUC
Peak height or C max ,[object Object],[object Object],[object Object]
Time of occurrence or t max ,[object Object],[object Object],[object Object]
(2) Urinary Drug excretion Data ,[object Object],[object Object],[object Object]
Urinary Drug excretion
(3)   Acute pharmacodynamic or pharmacologic effect ,[object Object],[object Object],[object Object]
Acute pharmacodynamic or pharmacologic effect ,[object Object],[object Object],[object Object]
Acute pharmacodynamic or pharmacologic effect
(4)   Clinical Observations ,[object Object],[object Object],[object Object]
(5)   In vitro Bioavailability studies ,[object Object],[object Object],[object Object],[object Object]
Gastrointestinal Bioavailability ,[object Object],[object Object],[object Object]
Gastrointestinal Bioavailability Oral suspension ,[object Object],[object Object],[object Object]
Oral suspension ,[object Object],[object Object]
Oral suspension ,[object Object],[object Object],[object Object],[object Object]
Oral suspension ,[object Object],[object Object],[object Object]
Oral suspension ,[object Object],[object Object]
Oral emulsion ,[object Object],[object Object],[object Object],[object Object],[object Object]
Dermatological Bioavailability ,[object Object],[object Object],[object Object],[object Object],[object Object]
Dermatological Bioavailability ,[object Object],[object Object],[object Object]
Dermatological Bioavailability ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Dermatological Bioavailability ,[object Object],[object Object],[object Object],[object Object],[object Object]
Measurement of Dermatological bioavailability ,[object Object],[object Object],[object Object],[object Object]
Procedure:  ,[object Object],[object Object],[object Object]
Ophthalmic Bioavailability ,[object Object],[object Object],[object Object]
Ophthalmic suspensions :   ,[object Object],[object Object],[object Object]
Ophthalmic suspensions :   ,[object Object],[object Object]
Ophthalmic suspensions : ,[object Object],[object Object],[object Object]
Ophthalmic ointments : ,[object Object],[object Object]
Ophthalmic ointments : ,[object Object],[object Object],[object Object]
Ophthalmic ointments : ,[object Object]
Rectal bioavailability : ,[object Object],[object Object],[object Object]
Rectal suppositories : ,[object Object],[object Object],[object Object],[object Object]
Rectal suppositories : ,[object Object],[object Object]

Contenu connexe

Tendances

FORMULATION FACTORS EFFECTING BIOAVAILABILITY OF DRUGS
FORMULATION FACTORS EFFECTING BIOAVAILABILITY OF DRUGSFORMULATION FACTORS EFFECTING BIOAVAILABILITY OF DRUGS
FORMULATION FACTORS EFFECTING BIOAVAILABILITY OF DRUGSN Anusha
 
Properties of GI tract, pH partition hypothesis
Properties of GI tract, pH partition hypothesis Properties of GI tract, pH partition hypothesis
Properties of GI tract, pH partition hypothesis Naveen Reddy
 
Dissolution study-Dissolution studies Factor affecting dissolution and Invitr...
Dissolution study-Dissolution studies Factor affecting dissolution and Invitr...Dissolution study-Dissolution studies Factor affecting dissolution and Invitr...
Dissolution study-Dissolution studies Factor affecting dissolution and Invitr...DRx.Yogesh Chaudhari
 
Evaluation of Controlled Drug Delivery Systems
Evaluation of Controlled Drug Delivery SystemsEvaluation of Controlled Drug Delivery Systems
Evaluation of Controlled Drug Delivery Systemswonderingsoul114
 
Transdermal drug delivery system (TDDS)
Transdermal drug delivery system (TDDS)Transdermal drug delivery system (TDDS)
Transdermal drug delivery system (TDDS)Sagar Savale
 
Formulation and Development of Matrix tablet In Drug Delivery System
Formulation and Development of Matrix tablet In Drug Delivery SystemFormulation and Development of Matrix tablet In Drug Delivery System
Formulation and Development of Matrix tablet In Drug Delivery SystemSayan Pramanik
 
Seminar (advance biopharmaceutics)
Seminar (advance biopharmaceutics)Seminar (advance biopharmaceutics)
Seminar (advance biopharmaceutics)Drx Shubham Badhe
 
Drug Absorption from GI Tract
Drug Absorption from GI TractDrug Absorption from GI Tract
Drug Absorption from GI Tractsilambarasan I
 
nasal drug delivery system
nasal drug delivery systemnasal drug delivery system
nasal drug delivery systemNeha Singh
 
Dissolution models (sem 1)
Dissolution models (sem 1)Dissolution models (sem 1)
Dissolution models (sem 1)HARSHALA DHENDE
 
Drug absorption from the gastrointestinal tract
Drug absorption from the gastrointestinal tractDrug absorption from the gastrointestinal tract
Drug absorption from the gastrointestinal tractakshatagavade1
 
Theories of drug dissolution
Theories of drug dissolutionTheories of drug dissolution
Theories of drug dissolutiontanmay93saha
 
Transmucosal drug delivery by Kailash Vilegave
Transmucosal drug delivery by Kailash VilegaveTransmucosal drug delivery by Kailash Vilegave
Transmucosal drug delivery by Kailash VilegaveKailash Vilegave
 
Design and fabrication of Oral-CRDDS....2 - Copy.pptx
Design and fabrication of Oral-CRDDS....2 - Copy.pptxDesign and fabrication of Oral-CRDDS....2 - Copy.pptx
Design and fabrication of Oral-CRDDS....2 - Copy.pptxSumant Saini
 
Dissolution method and ivivc by ranjeet singh
Dissolution method and ivivc by ranjeet singhDissolution method and ivivc by ranjeet singh
Dissolution method and ivivc by ranjeet singhRanjeet Singh
 
Dissolution and In Vitro In Vivo Correlation (IVIVC)
Dissolution and In Vitro In Vivo Correlation (IVIVC)Dissolution and In Vitro In Vivo Correlation (IVIVC)
Dissolution and In Vitro In Vivo Correlation (IVIVC)Jaspreet Guraya
 
Osmotic drug delivery system
Osmotic drug delivery systemOsmotic drug delivery system
Osmotic drug delivery systemdoll969
 

Tendances (20)

FORMULATION FACTORS EFFECTING BIOAVAILABILITY OF DRUGS
FORMULATION FACTORS EFFECTING BIOAVAILABILITY OF DRUGSFORMULATION FACTORS EFFECTING BIOAVAILABILITY OF DRUGS
FORMULATION FACTORS EFFECTING BIOAVAILABILITY OF DRUGS
 
Properties of GI tract, pH partition hypothesis
Properties of GI tract, pH partition hypothesis Properties of GI tract, pH partition hypothesis
Properties of GI tract, pH partition hypothesis
 
Dissolution study-Dissolution studies Factor affecting dissolution and Invitr...
Dissolution study-Dissolution studies Factor affecting dissolution and Invitr...Dissolution study-Dissolution studies Factor affecting dissolution and Invitr...
Dissolution study-Dissolution studies Factor affecting dissolution and Invitr...
 
Evaluation of Controlled Drug Delivery Systems
Evaluation of Controlled Drug Delivery SystemsEvaluation of Controlled Drug Delivery Systems
Evaluation of Controlled Drug Delivery Systems
 
Transdermal drug delivery system (TDDS)
Transdermal drug delivery system (TDDS)Transdermal drug delivery system (TDDS)
Transdermal drug delivery system (TDDS)
 
Formulation and Development of Matrix tablet In Drug Delivery System
Formulation and Development of Matrix tablet In Drug Delivery SystemFormulation and Development of Matrix tablet In Drug Delivery System
Formulation and Development of Matrix tablet In Drug Delivery System
 
Control drug delivery system
Control drug delivery systemControl drug delivery system
Control drug delivery system
 
Seminar (advance biopharmaceutics)
Seminar (advance biopharmaceutics)Seminar (advance biopharmaceutics)
Seminar (advance biopharmaceutics)
 
Drug Absorption from GI Tract
Drug Absorption from GI TractDrug Absorption from GI Tract
Drug Absorption from GI Tract
 
nasal drug delivery system
nasal drug delivery systemnasal drug delivery system
nasal drug delivery system
 
Dissolution models (sem 1)
Dissolution models (sem 1)Dissolution models (sem 1)
Dissolution models (sem 1)
 
Drug absorption from the gastrointestinal tract
Drug absorption from the gastrointestinal tractDrug absorption from the gastrointestinal tract
Drug absorption from the gastrointestinal tract
 
Theories of drug dissolution
Theories of drug dissolutionTheories of drug dissolution
Theories of drug dissolution
 
Transmucosal drug delivery by Kailash Vilegave
Transmucosal drug delivery by Kailash VilegaveTransmucosal drug delivery by Kailash Vilegave
Transmucosal drug delivery by Kailash Vilegave
 
Design and fabrication of Oral-CRDDS....2 - Copy.pptx
Design and fabrication of Oral-CRDDS....2 - Copy.pptxDesign and fabrication of Oral-CRDDS....2 - Copy.pptx
Design and fabrication of Oral-CRDDS....2 - Copy.pptx
 
Dissolution method and ivivc by ranjeet singh
Dissolution method and ivivc by ranjeet singhDissolution method and ivivc by ranjeet singh
Dissolution method and ivivc by ranjeet singh
 
Dissolution
DissolutionDissolution
Dissolution
 
Dissolution and In Vitro In Vivo Correlation (IVIVC)
Dissolution and In Vitro In Vivo Correlation (IVIVC)Dissolution and In Vitro In Vivo Correlation (IVIVC)
Dissolution and In Vitro In Vivo Correlation (IVIVC)
 
Transferosomes
TransferosomesTransferosomes
Transferosomes
 
Osmotic drug delivery system
Osmotic drug delivery systemOsmotic drug delivery system
Osmotic drug delivery system
 

Similaire à Bioavailability Of Disperse Dosage Form

Diffusion finals, feb 29, 2012
Diffusion finals, feb 29, 2012Diffusion finals, feb 29, 2012
Diffusion finals, feb 29, 2012eckotanglao
 
Buccal drug delivery systems
Buccal drug delivery systemsBuccal drug delivery systems
Buccal drug delivery systemshardik dhiman
 
Buccal drug delivery systems
Buccal drug delivery systemsBuccal drug delivery systems
Buccal drug delivery systemshardik dhiman
 
Ocular bioavailability
Ocular bioavailabilityOcular bioavailability
Ocular bioavailabilitysneha chavan
 
Controlled release oral drug delivery
Controlled release oral drug deliveryControlled release oral drug delivery
Controlled release oral drug deliveryGaurav Kr
 
ocular barriers and methods to overcome barriers
ocular barriers and methods to overcome barriersocular barriers and methods to overcome barriers
ocular barriers and methods to overcome barriersTarun Gollapudi
 
mucoadhesive drug delivery system.pptx
mucoadhesive drug delivery system.pptxmucoadhesive drug delivery system.pptx
mucoadhesive drug delivery system.pptxRevathykrishnan13
 
Ocular drug delivery systems
Ocular drug delivery systemsOcular drug delivery systems
Ocular drug delivery systemsSnehaPachore
 
Orodispersible liquisolid compacts
Orodispersible liquisolid compactsOrodispersible liquisolid compacts
Orodispersible liquisolid compactsPranali Palandurkar
 
Formulation and evaluation of rosiglitazone nanosuspension
Formulation and evaluation of rosiglitazone nanosuspensionFormulation and evaluation of rosiglitazone nanosuspension
Formulation and evaluation of rosiglitazone nanosuspensionSriramNagarajan19
 
Jaideep Sarkar- Buccomucosal Drug Delivery System
Jaideep Sarkar- Buccomucosal Drug Delivery SystemJaideep Sarkar- Buccomucosal Drug Delivery System
Jaideep Sarkar- Buccomucosal Drug Delivery SystemGlaxoSmithKline Pharma GmbH
 
ocular drug delivery
ocular drug deliveryocular drug delivery
ocular drug deliveryJayeshRajput7
 
Unit III_Transdermal DDS.pdf
Unit III_Transdermal DDS.pdfUnit III_Transdermal DDS.pdf
Unit III_Transdermal DDS.pdfbijaybhattarai942
 
Mechanism of dds1
Mechanism of dds1Mechanism of dds1
Mechanism of dds1Sachin G
 
Drug Absorption(Ver 20.0).pptx
Drug Absorption(Ver 20.0).pptxDrug Absorption(Ver 20.0).pptx
Drug Absorption(Ver 20.0).pptxChangbaeg Lim
 
Drug Absorption(Ver 20.0).pptx
Drug Absorption(Ver 20.0).pptxDrug Absorption(Ver 20.0).pptx
Drug Absorption(Ver 20.0).pptxChangbaeg Lim
 

Similaire à Bioavailability Of Disperse Dosage Form (20)

Diffusion finals, feb 29, 2012
Diffusion finals, feb 29, 2012Diffusion finals, feb 29, 2012
Diffusion finals, feb 29, 2012
 
Ndds
NddsNdds
Ndds
 
Buccal drug delivery systems
Buccal drug delivery systemsBuccal drug delivery systems
Buccal drug delivery systems
 
Buccal drug delivery systems
Buccal drug delivery systemsBuccal drug delivery systems
Buccal drug delivery systems
 
Ocular bioavailability
Ocular bioavailabilityOcular bioavailability
Ocular bioavailability
 
Controlled release oral drug delivery
Controlled release oral drug deliveryControlled release oral drug delivery
Controlled release oral drug delivery
 
ocular barriers and methods to overcome barriers
ocular barriers and methods to overcome barriersocular barriers and methods to overcome barriers
ocular barriers and methods to overcome barriers
 
mucoadhesive drug delivery system.pptx
mucoadhesive drug delivery system.pptxmucoadhesive drug delivery system.pptx
mucoadhesive drug delivery system.pptx
 
Ocular drug delivery systems
Ocular drug delivery systemsOcular drug delivery systems
Ocular drug delivery systems
 
Orodispersible liquisolid compacts
Orodispersible liquisolid compactsOrodispersible liquisolid compacts
Orodispersible liquisolid compacts
 
Formulation and evaluation of rosiglitazone nanosuspension
Formulation and evaluation of rosiglitazone nanosuspensionFormulation and evaluation of rosiglitazone nanosuspension
Formulation and evaluation of rosiglitazone nanosuspension
 
Jaideep Sarkar- Buccomucosal Drug Delivery System
Jaideep Sarkar- Buccomucosal Drug Delivery SystemJaideep Sarkar- Buccomucosal Drug Delivery System
Jaideep Sarkar- Buccomucosal Drug Delivery System
 
Lec 4 & 5
Lec 4 & 5Lec 4 & 5
Lec 4 & 5
 
General pharmacology
General pharmacologyGeneral pharmacology
General pharmacology
 
ocular drug delivery
ocular drug deliveryocular drug delivery
ocular drug delivery
 
Ocular Drug Delivery System.pptx
Ocular Drug Delivery System.pptxOcular Drug Delivery System.pptx
Ocular Drug Delivery System.pptx
 
Unit III_Transdermal DDS.pdf
Unit III_Transdermal DDS.pdfUnit III_Transdermal DDS.pdf
Unit III_Transdermal DDS.pdf
 
Mechanism of dds1
Mechanism of dds1Mechanism of dds1
Mechanism of dds1
 
Drug Absorption(Ver 20.0).pptx
Drug Absorption(Ver 20.0).pptxDrug Absorption(Ver 20.0).pptx
Drug Absorption(Ver 20.0).pptx
 
Drug Absorption(Ver 20.0).pptx
Drug Absorption(Ver 20.0).pptxDrug Absorption(Ver 20.0).pptx
Drug Absorption(Ver 20.0).pptx
 

Dernier

On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsMebane Rash
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxDenish Jangid
 
How to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxHow to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxCeline George
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024Elizabeth Walsh
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptxMaritesTamaniVerdade
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibitjbellavia9
 
Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxJisc
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the ClassroomPooky Knightsmith
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxAreebaZafar22
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and ModificationsMJDuyan
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxEsquimalt MFRC
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfSherif Taha
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfPoh-Sun Goh
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxDr. Ravikiran H M Gowda
 
Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Association for Project Management
 
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...pradhanghanshyam7136
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - Englishneillewis46
 
Spellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please PractiseSpellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please PractiseAnaAcapella
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17Celine George
 

Dernier (20)

On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
How to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxHow to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptx
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptx
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the Classroom
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptx
 
Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...
 
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
Spellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please PractiseSpellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please Practise
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 

Bioavailability Of Disperse Dosage Form

  • 1. Bioavailability Of Disperse Dosage Forms By Mohammad Sohail Mphil pharmaceutics Islamia university Bahawalpur [email_address]
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8. AB vs RBA Drug Product AUC ( mcg/ml . hr ) A IV Injection 100 B Oral dosage form (Refer) 50 C Oral dosage form (generic) 40
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 24.
  • 25.
  • 27.
  • 28.
  • 30.
  • 31.
  • 32.
  • 33.
  • 34. Absorption Factors SKIN EYE GIT Barrier Stratum corneum Superficial layer of epithelium Epithelium Thickness 8-26 layers 5-6 layers 1 layer hydration 10-25% 78% High area 2-25cm 2 1.3cm 2 2,000,000
  • 35.
  • 36.
  • 37.
  • 38.
  • 39.
  • 40.
  • 41.
  • 42.
  • 43.
  • 44.
  • 45. pH Location pH Stomach Duodenum Jejunum Ileum Colon Rectum 1.5-3.5 5-7 6-7 6.0-7.5 5.5-7.0 7
  • 46.
  • 47.
  • 48.
  • 49.
  • 50.
  • 51.
  • 52.
  • 53.
  • 54.
  • 55.
  • 56.
  • 57.
  • 58.
  • 59.
  • 60. Plasma concentration vs. time profile of a single dose of a drug ingested orally Plasma Concentration
  • 61.
  • 62. AUC
  • 63.
  • 64.
  • 65.
  • 67.
  • 68.
  • 69. Acute pharmacodynamic or pharmacologic effect
  • 70.
  • 71.
  • 72.
  • 73.
  • 74.
  • 75.
  • 76.
  • 77.
  • 78.
  • 79.
  • 80.
  • 81.
  • 82.
  • 83.
  • 84.
  • 85.
  • 86.
  • 87.
  • 88.
  • 89.
  • 90.
  • 91.
  • 92.
  • 93.
  • 94.